321 related articles for article (PubMed ID: 35269860)
1. The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation.
Virmani MA; Cirulli M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269860
[TBL] [Abstract][Full Text] [Related]
2. Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine.
Marcovina SM; Sirtori C; Peracino A; Gheorghiade M; Borum P; Remuzzi G; Ardehali H
Transl Res; 2013 Feb; 161(2):73-84. PubMed ID: 23138103
[TBL] [Abstract][Full Text] [Related]
3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
5. [Carnitine deficiency].
Schmidt-Sommerfeld E; Penn D
Monatsschr Kinderheilkd; 1986 May; 134(5):224-31. PubMed ID: 3014317
[TBL] [Abstract][Full Text] [Related]
6. Aspects of long-chain acyl-COA metabolism.
Tol VA
Mol Cell Biochem; 1975 Apr; 7(1):19-31. PubMed ID: 1134497
[TBL] [Abstract][Full Text] [Related]
7. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
Singh H; Beckman K; Poulos A
J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
[TBL] [Abstract][Full Text] [Related]
8. Significance of l-carnitine for human health.
Adeva-Andany MM; Calvo-Castro I; Fernández-Fernández C; Donapetry-García C; Pedre-Piñeiro AM
IUBMB Life; 2017 Aug; 69(8):578-594. PubMed ID: 28653367
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial β-oxidation of saturated fatty acids in humans.
Adeva-Andany MM; Carneiro-Freire N; Seco-Filgueira M; Fernández-Fernández C; Mouriño-Bayolo D
Mitochondrion; 2019 May; 46():73-90. PubMed ID: 29551309
[TBL] [Abstract][Full Text] [Related]
10. The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.
Virmani A; Pinto L; Bauermann O; Zerelli S; Diedenhofen A; Binienda ZK; Ali SF; van der Leij FR
Mol Neurobiol; 2015 Oct; 52(2):826-36. PubMed ID: 26041663
[TBL] [Abstract][Full Text] [Related]
11. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
Brady LJ; Brady PS; Gandour RD
Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
[TBL] [Abstract][Full Text] [Related]
12. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle.
Knottnerus SJG; Bleeker JC; Wüst RCI; Ferdinandusse S; IJlst L; Wijburg FA; Wanders RJA; Visser G; Houtkooper RH
Rev Endocr Metab Disord; 2018 Mar; 19(1):93-106. PubMed ID: 29926323
[TBL] [Abstract][Full Text] [Related]
13. Primary and secondary carnitine deficiency syndromes.
Pons R; De Vivo DC
J Child Neurol; 1995 Nov; 10 Suppl 2():S8-24. PubMed ID: 8576570
[TBL] [Abstract][Full Text] [Related]
14. The role of carnitine in intracellular metabolism.
Bremer J
J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
[TBL] [Abstract][Full Text] [Related]
15. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.
Houten SM; Wanders RJA; Ranea-Robles P
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165720. PubMed ID: 32057943
[TBL] [Abstract][Full Text] [Related]
16. L-carnitine is essential to beta-oxidation of quarried fatty acid from mitochondrial membrane by PLA(2).
Yano H; Oyanagi E; Kato Y; Samejima Y; Sasaki J; Utsumi K
Mol Cell Biochem; 2010 Sep; 342(1-2):95-100. PubMed ID: 20443048
[TBL] [Abstract][Full Text] [Related]
17. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of beta-oxidation.
Angelini C; Vergani L; Martinuzzi A
Crit Rev Clin Lab Sci; 1992; 29(3-4):217-42. PubMed ID: 1489518
[TBL] [Abstract][Full Text] [Related]
19. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
Virmani A; Gaetani F; Binienda Z
Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
[TBL] [Abstract][Full Text] [Related]
20. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
Calvani M; Reda E; Arrigoni-Martelli E
Basic Res Cardiol; 2000 Apr; 95(2):75-83. PubMed ID: 10826498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
